Literature DB >> 19201426

Mesenteric lymphatic ducts ligation decreases the degree of gut-induced lung injury in a portal vein occlusion and reperfusion canine model.

Chang Liu1, Qifei Wu, Quanyuan Li, Dong Liu, Haibo Su, Naiying Shen, Minghui Tai, Yi Lv.   

Abstract

BACKGROUND: Whether the mesenteric lymphatic system could serve as a route of transport by which gut-derived inflammatory mediators contribute to the induction of remote organ injuries is uncertain. We therefore made a gut-induced lung injury canine model by portal vein occlusion and reperfusion (PV O/R) and studied the role of mesenteric lymphatic ducts ligation (ML) to gut-induced lung injury with this model.
MATERIAL AND METHODS: Eighteen mongrel dogs were divided into control, PV O/R, and PV O/R + ML groups. Cytokines and endotoxin levels in the portal vein and lymph from thoracic duct in different groups were tested. The permeability, myeloperoxidase activity, and histopathological investigation of intestine and lung were evaluated.
RESULTS: Cytokines and endotoxin levels in the portal vein were significantly increased in experimental groups compared with control group (P < 0.05), and that in the lymph from thoracic duct were significantly increased in PV O/R group compared with control and PV O/R + ML group (P < 0.05). Lung permeability and MPO activity in PV O/R group were significantly higher than those in control and PV O/R + ML group (P < 0.05); intestinal permeability in experimental groups were significantly higher with respect to control group. The lung injury score in PV O/R group was significantly higher than those in control and PV O/R + ML group (P < 0.05) and the intestinal injury scores in experimental groups were significantly higher than control group (P < 0.05).
CONCLUSIONS: The gut-induced lung injury canine model made by PV O/R is successful, and mesenteric lymphatic ducts ligation decreases the degree of gut-induced lung injury in this model.

Entities:  

Mesh:

Year:  2008        PMID: 19201426     DOI: 10.1016/j.jss.2008.06.006

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

1.  Peritoneal fluid: a potential mechanism of systemic neutrophil priming in experimental intra-abdominal sepsis.

Authors:  Shinil K Shah; Fernando Jimenez; Peter A Walker; Hasen Xue; Teri D Feeley; Karen S Uray; Kenneth C Norbury; Randolph H Stewart; Glen A Laine; Charles S Cox
Journal:  Am J Surg       Date:  2011-06-16       Impact factor: 2.565

2.  Beta-1 blocker improves survival of septic rats through preservation of gut barrier function.

Authors:  Katsuya Mori; Hiroshi Morisaki; Satoshi Yajima; Takeshi Suzuki; Akiko Ishikawa; Norihito Nakamura; Yasushi Innami; Junzo Takeda
Journal:  Intensive Care Med       Date:  2011-08-17       Impact factor: 17.440

Review 3.  Strategies for modulating the inflammatory response after decompression from abdominal compartment syndrome.

Authors:  Shinil K Shah; Fernando Jimenez; Phillip A Letourneau; Peter A Walker; Stacey D Moore-Olufemi; Randolph H Stewart; Glen A Laine; Charles S Cox
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2012-04-03       Impact factor: 2.953

4.  Active Negative Pressure Peritoneal Therapy After Abbreviated Laparotomy: The Intraperitoneal Vacuum Randomized Controlled Trial.

Authors:  Andrew W Kirkpatrick; Derek J Roberts; Peter D Faris; Chad G Ball; Paul Kubes; Corina Tiruta; Zhengwen Xiao; Jessalyn K Holodinsky; Paul B McBeth; Christopher J Doig; Craig N Jenne
Journal:  Ann Surg       Date:  2015-07       Impact factor: 12.969

5.  Intra-Abdominal Hypertension Causes Bacterial Growth in Lungs: An Animal Study.

Authors:  Eleni Papakrivou; Demosthenes Makris; Efstratios Manoulakas; Magda Mitroudi; Konstantinos Tepetes; Konstantinos Papazoglou; Epaminondas Zakynthinos
Journal:  Biomed Res Int       Date:  2017-03-05       Impact factor: 3.411

Review 6.  Inflammatory mediators in intra-abdominal sepsis or injury - a scoping review.

Authors:  Zhengwen Xiao; Crystal Wilson; Helen Lee Robertson; Derek J Roberts; Chad G Ball; Craig N Jenne; Andrew W Kirkpatrick
Journal:  Crit Care       Date:  2015-10-27       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.